N-(3-Aminopropyl)[3-(4-Fluorophenyl)(1H-Indazol-5-yl)]Carboxamide

ID: ALA3986679

PubChem CID: 22479969

Max Phase: Preclinical

Molecular Formula: C17H17FN4O

Molecular Weight: 312.35

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NCCCNC(=O)c1ccc2[nH]nc(-c3ccc(F)cc3)c2c1

Standard InChI:  InChI=1S/C17H17FN4O/c18-13-5-2-11(3-6-13)16-14-10-12(4-7-15(14)21-22-16)17(23)20-9-1-8-19/h2-7,10H,1,8-9,19H2,(H,20,23)(H,21,22)

Standard InChI Key:  MIXVCLBTONMNTK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   16.8748   -8.2874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8737   -9.1070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5817   -9.5159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5799   -7.8786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2886   -8.2838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2933   -9.1024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0734   -9.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5507   -8.6858    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.0656   -8.0264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.3291  -10.1220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7841  -10.7324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0406  -11.5075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8417  -11.6734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3858  -11.0580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1264  -10.2853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0997  -12.4488    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.1656   -9.5150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4583   -9.1059    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1650  -10.3322    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7502   -9.5139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0428   -9.1047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3348   -9.5128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6274   -9.1036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  7 10  1  0
 13 16  1  0
  2 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
M  END

Associated Targets(Human)

MAPK9 Tchem c-Jun N-terminal kinase 2 (4655 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 312.35Molecular Weight (Monoisotopic): 312.1386AlogP: 2.45#Rotatable Bonds: 5
Polar Surface Area: 83.80Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.58CX Basic pKa: 9.77CX LogP: 1.81CX LogD: -0.48
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.63Np Likeness Score: -1.39

References

1.  (2002)  Indazole derivatives as JNK inhibitors and compositions and methods related thereto, 

Source